Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: A possible alternative

Rheumatology

Volumn 43, Issue 11, 2004, Pages 1383-1385

  Lampropoulos, C E ^a   Sangle, S ^a   Harrison, P ^a   Hughes, G R V ^a   D'Cruz, David P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cutaneous lupus erythematosus; Tacrolimus

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETAMETHASONE; CLARITHROMYCIN; CLOBETASOL; CLOBETASOL BUTYRATE; CYCLOPHOSPHAMIDE; DAPSONE; ETODOLAC; FEXOFENADINE; HYDROXYCHLOROQUINE; MEPACRINE; METHOTREXATE; METHYLPREDNISOLONE; MOMETASONE FUROATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; THALIDOMIDE; URSODEOXYCHOLIC ACID; VENLAFAXINE; WARFARIN;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PHOTOSENSITIVITY; PRIORITY JOURNAL; RASH; REMISSION; SIDE EFFECT; SKIN ABRASION; SKIN LUPUS ERYTHEMATOSUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 8344238921     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh325     Document Type: Article

References (20)

1. Ting WW, Sontheimer RD. Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations. Lupus 2001;10:171-84.
2. Homey B, Assmann T, Vohr HW et al. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J Immunol 1998;160:5331-40.
3. Starzl TE, Todo S, Fung J. FK506 for liver, kidney and pancreas transplantation. Lancet 1989;8670:1000-4.
4. US FDA Advisory Committee recommends approval for Tacrolimus ointment. Skin Ther Lett 2000;6:5.
5. Bos JD. Non-steroidal topical immunomodulators provide skin-selective and self-limiting treatment in atopic dermatitis. Eur J Dermatol 2003;13:455-61.
6. Soter NA, Fleischer AB, Webster OF. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. Am Acad Dermatol 2001;44(Suppl 1):S39-S46.
7. Yamamoto T, Nishioka K. Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol 2003;13:471-3.
8. Mancuso G, Berdondini RM. Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol 2003;13:590-2.
9. Evans A, Palmer R, Hawk J. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed 2004;20:59-61.
10. Petering H, Kiehl P, Breuer C et al. Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506). Hautarzt 2001; 52:47-50.
11. Sakane T, Mochizuki M, Inaba G, Masuda K. A phase 11 study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions. Ryumachi 1995;35:802-13.
12. Lener EV, Brieva J, Schachter M et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001;137: 419-22.
13. Schuppe H, Richter-Hintz D, Stierle HE et al. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis. Rheumatology 2000;39:105-6.
14. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001; 44:995-8.
15. Karim MY, Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Update on therapy - thalidomide in the treatment of lupus. Lupus 2001;10: 188-92.
16. Ellis CN, Drake LA, Prendergast MM et al. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. J Am Acad Dermatol 2003;48:553-63.
17. Druke A, Gambichler T, Altmeyer P, Freitag M, Kreuter A. 0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus. J Dermatol Treat 2004;15:63-4.
18. Bohm M, Gaubitz M, Luger TA, Metze D, Bonsmann G. Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases. Dermatology 2003;207: 381-5.
19. Walker SL, Kirby B, Chalmers RJG. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002;147:405-6.
20. Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002;12:50-2.